Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



Hepatitis C Weak Spot, Target for Drug Research


Hepatitis C Weak Spot, Target for Drug Research

Viruses are considered to be the tiniest creatures discovered. However, they are on top of the most fatal creatures to humans. Obviously each type of viruses has a preferred target. HIV targets the immune system, while hepatitis C slowly destroys the liver in the absence of a successful treatment or vaccine.

A new study, conducted by University of Warwick, discovered a “switch” in the hepatitis C virus which could be used as a target for new kinds of drug treatment.

Professor David Evans of the University of Warwick said: “Hepatitis C is a growing concern worldwide and is set to place a massive demand on the organ transplant system. We are already at the stage in many countries where the main need for liver transplants is due to liver damage caused by the Hepatitis C virus.

The study, published in Nucleic Acids Research, found that most of hepatitis C viruses have a “switch” which researchers see as a target for chemical treatment during the early replication stages. In other words, researchers hope to prevent the virus from attacking more liver cells by stopping its early replication by targeting its weak points, leaving the remaining very few viruses to the immune system which can handle them.

“Current medication is not effective in all cases, that’s why it’s vital that we continue to build on this early-stage research to focus drug development work on treatment which works across all Hepatitis C genotypes.” Evans concluded.



Prepared by: Abdullatief Janat


Source :

ePharmaNews






Other Comments

Add a comment

You must sign in to use this servcie

Username:
Password:


facebook comments

Forgot your password


sign up

Consultants Corner

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details